Article
Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?
Vaccine - 2 Jun 2003
Clarke S C, Diggle M A, Mölling P, Unemo M, Olcén P
Abstract excerpt
Outer membrane protein (OMP) vaccines are being developed against Neisseria meningitidis serogroup B which may provide protection against common circulating serotypes and serosubtypes in some countries. However, limited data is available in Europe from genosubtyping meningococci. We therefore undertook a retrospective analysis of the three main variable regions, VR1, VR2 as well as VR3, of the porA gene from N....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
